clinical
ALS Clinical
Approved for sale in Europe, CE Registration #518356 .
"US Investigational Device, not currently available for sale in the US .
Initial study of the device in ALS provided the feasibility of using diaphragmic pacing to slow the decline in a patient's Forced Vital Capacity and delay the onset of respiratory failure. Data from our pilot study revealed the average pre-implant rate of decline was calculated at -2.8% per month and for patients with at least 9 months post-implant follow-up the rate improved to
-1.0% per month.
We are also investigating to determine if the NeuRx DPS™ may be effective in ventilatory support of patients with ALS either decreasing or eliminating the need for negative or positive pressure mechanical ventilation.
Read testimonials from patients just like you.
Download the ALS Patient/Caregiver Brochure [PDF]
View ALS Patient/Caregiver Video
Or for information about the open ALS clinical trial please contact:
| Study | Hospital Name | Coordinators |
#1 |
University Hospitals of Cleveland Cleveland, OH 44106 |
Mary Jo Elmo, ACNP Office (216) 844-8594 maryjo.elmo@uhhs.com |
| #2 | Johns Hopkins University Baltimore, MD 21287 |
Laura Clawson-Research Coordinator Office (410) 955-8511 lclawson@jhmi.edu |
| #3 | Stanford University Stanford, CA 94305 |
Shirley Paulose-Research Assistant, Neurology Office (650) 724-3792 spaulose@stanford.edu |
| #4 | Methodist Neurological Institute Houston, Texas 77030 |
Luis F. Lay, Jr.-Senior Research Coordinator Office (713) 441-3057 LFLayJr@tmhs.org |
| #5 | Henry Ford Health System Detroit, MI. 48202 |
Helen Foley-Research Coordinator Office (313) 916-3955 helen@neuro.hfh.edu |
| #6 | Mayo Clinic Jacksonville, FL 32224 |
Karen Overstreet-ALS Research Coordinator Office (904) 953-8946 Overstreet.Karen@mayo.edu |
| #7 | California Pacific Medical Center (CPMC) San Francisco, CA 94115 |
Dallas Forshew-Manager, ALS Research Office (415)600-3604 forshed@cpmcri.org |